Product Categories
| Country: | China |
|---|---|
| Tel: | 021-18017925 |
| Mobile: | +8618916360931 |
| E-mail: | 2596183085@qq.com |
| QQ: | 2596183085 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Xeligekimab | 2382921-73-3 | Details |
| Terbutaline | C12H19NO3 | 23031-25-6 | Details |
| EMD57439 | C22H23N3O4S | 148714-88-9 | Details |
| Amivantamab | 2171511-58-1 | Details |
| Cis-22a | C24H30F3N3O2 | 1819366-84-1 | Details |
| Tesnatilimab | 2242758-08-1 | Details |
| K34C | C26H29N3O4 | 939769-93-4 | Details |
| Spinorphin | C45H64N8O10 | 137201-62-8 | Details |
| TC-N 22A | C14H13N5S | 1314140-00-5 | Details |
| CRT-0105950 | C21H16ClN3OS | 1661845-86-8 | Details |
| UC-514321 | C26H35NO5 | 299420-83-0 | Details |
| MHY-1685 | C11H8N2O4 | 27406-31-1 | Details |
| Galanin (1-16), mouse, porcine, rat | C78H116N20O21 | 125118-77-6 | Details |
| Kansuinine A | C37H46O15 | 57701-86-7 | Details |
| Adropin (34-76) (human, mouse, rat) | 1802086-30-1 | Details |
| Siplizumab | 288392-69-8 | Details |
| Solabegron | C23H23ClN2O3 | 252920-94-8 | Details |
| JAK-IN-11 | C23H22FN5O4S | 916742-11-5 | Details |
| Rutaevin | C26H30O9 | 33237-37-5 | Details |
| Nidanilimab | 2171061-85-9 | Details |
| RJW100 | C28H34O | 1276664-20-0 | Details |
| S1R agonist 2 | C21H27NO | 150085-21-5 | Details |
| CSF1R-IN-3 | C30H38N8O4 | 2760584-90-3 | Details |
| Plogosertib | C34H48N8O3 | 1137212-79-3 | Details |
| Uplarafenib | C22H21F3N4O4S | 1425485-87-5 | Details |
| Asthma relating compound 1 | C17H19N3O3S2 | 120165-51-7 | Details |
| Isoangustone A | C25H26O6 | 129280-34-8 | Details |
| Lys-SMCC-DM1 | C53H75ClN6O15S | 1281816-04-3 | Details |
| Rhamnazin | C17H14O7 | 552-54-5 | Details |
| 6-Hydroxy-2-phenethylchromone | C17H14O3 | 84294-90-6 | Details |
| UK-396082 | C12H21N3O2 | 400044-47-5 | Details |
| CDK9-IN-8 | C31H32FN7O3 | 2105956-51-0 | Details |
| TLR7/8/9-IN-1 | C27H37N3O2 | 2180127-82-4 | Details |
| N-Acetyl-β-Asp-Glu | C11H16N2O8 | 4910-46-7 | Details |
| Tomatidine | C27H45NO2 | 77-59-8 | Details |
| Naxitamab | 1879925-92-4 | Details |
| Zinc Phytate | C6H18O24P6Zn | 63903-51-5 | Details |
| Apostatin-1 | C19H27N3OS | 2559703-06-7 | Details |
| Pidobenzone | C11H11NO4 | 138506-45-3 | Details |
| UCM-05194 | C19H30BrO6P | 2411412-36-5 | Details |
| Nimotuzumab | 828933-51-3 | Details |
| BMS-688521 | C26H19Cl2N5O4 | 893397-44-9 | Details |
| Flumethasone pivalate | C27H36F2O6 | 2002-29-1 | Details |
| Cobolimab | 2022215-65-0 | Details |
| Phorbol 12,13-dibutyrate | C28H40O8 | 37558-16-0 | Details |
| Pobilukast | C26H34O5S | 107023-41-6 | Details |
| PERK-IN-6 | C23H22N6O | 1337532-14-5 | Details |
| Yadanzioside F | C29H38O16 | 95258-11-0 | Details |
| GSK-3β inhibitor 8 | C20H20ClN5OS | 1139875-74-3 | Details |
| Timcodar | C43H45ClN4O6 | 179033-51-3 | Details |
| NH-bis(PEG3-azide) | C16H33N7O6 | 1258939-39-7 | Details |
| Thyrotropin-Releasing Hormone (TRH), Free Acid | C16H21N5O5 | 24769-58-2 | Details |
| (±)-Acetylcarnitine chloride | C9H18ClNO4 | 2504-11-2 | Details |
| GSK299115A | C20H16Cl2N4O2 | 864082-35-9 | Details |
| CDDO-dhTFEA | C33H45F3N2O3 | 1191265-33-4 | Details |
| Onvatilimab | 1969313-51-6 | Details |
| AF-710B | C20H27N3OS | 1235733-73-9 | Details |
| Phenothiazine Analogues | C15H13ClN2OS | 423749-25-1 | Details |
| BMS-593214 | C31H27N3O4 | 1004551-40-9 | Details |
| SN50 | C129H230N36O29S | 213546-53-3 | Details |
| L162389 | C31H38N4O4S | 169281-53-2 | Details |
| Oleyl Mesylate | C19H38O3S | 35709-09-2 | Details |
| Verbasoside | C20H30O12 | 61548-34-3 | Details |
| Bcl-xL antagonist 2 | C21H16N4O3S2 | 1235032-75-3 | Details |
| MLN-4760 | C19H23Cl2N3O4 | 305335-31-3 | Details |
| GGTI-2133 | C27H28N4O3 | 191102-79-1 | Details |
| Sutimlimab | 2049079-64-1 | Details |
| Lenumlostat | C18H17F4N3O3 | 2098884-52-5 | Details |
| 18α-Glycyrrhetinic acid | C30H46O4 | 1449-05-4 | Details |
| Hastatoside | C17H24O11 | 50816-24-5 | Details |
| Vialinin A | C34H26O8 | 858134-23-3 | Details |
| BMS-906024 | C26H26F6N4O3 | 1401066-79-2 | Details |
| CH 5450 | C34H44N4O9 | 252557-97-4 | Details |
| KT203 | C28H26N4O3 | 1402612-64-9 | Details |
| FIT-039 | C17H18FN3S | 1113044-49-7 | Details |
| Jionoside A1 | C36H48O20 | 120444-60-2 | Details |
| Sodium methanearsonate | CH4AsO3.Na | 2163-80-6 | Details |
| Djenkolic Acid | C7H14N2O4S2 | 498-59-9 | Details |
| BI-4924 | C21H20Cl2N2O6S | 2244452-09-1 | Details |
| Patritumab | 1262787-83-6 | Details |
| SBI-477 | C24H25N3O6S | 781628-99-7 | Details |
| Ontuxizumab | 946415-62-9 | Details |
| CT-2584 | C30H55N5O3 | 166981-13-1 | Details |
| Xipamide | C15H15ClN2O4S | 14293-44-8 | Details |
| PQR514 | C16H20F2N8O2 | 1927857-55-3 | Details |
| Coryneine | C11H18NO2 | 7224-66-0 | Details |
| Lexatumumab | 845816-02-6 | Details |
| (+/-)-Marmesin | C14H14O4 | 13710-70-8 | Details |
| Olaratumab | 1024603-93-7 | Details |
| FMF-04-159-2 | C28H30Cl3N7O5S | 2364489-81-4 | Details |
| AY 77 | C21H32N4O4 | 1835734-92-3 | Details |
| Naluzotan hydrochloride | C23H39ClN4O3S | 740873-82-9 | Details |
| ALOX15-IN-2 | C23H29N3O4S | 2764818-23-5 | Details |
| L-692429 | C29H31N7O2 | 145455-23-8 | Details |
| Ofatumumab | 679818-59-8 | Details |
| (6R,7S)-Cefminox sodium heptahydrate | C16H24N7NaO8S3 | 92636-39-0 | Details |
| BI-135585 | C28H32N2O4 | 1114561-85-1 | Details |
| Vunakizumab | 1792181-33-9 | Details |
| DS-1205 | C41H42FN5O7 | 1855860-24-0 | Details |
| JR-AB2-011 | C17H14Cl2FN3OS | 2411853-34-2 | Details |
| Product Total： Product Page： | ||||
| 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 | ||||